Evidence map›Paper›PMID 41017640›Full record

ArticleNeuro-oncology2025

Response to: Bayesian -reappraisal of ACNS0332 and ACNS0334 strengthens -subgroup treatment effects in high-risk pediatric group 3 medulloblastoma.

Guolian Kang, Sarah E S Leary, Arzu Onar-Thomas, Yimei Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Guolian KangDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee (G.K., A.O-T., Y.L.); Department of Pediatrics, Seattle Children's, Seattle, Washington (S.E.S.L.).ORCID 0000-0002-6102-0115
Sarah E S LearyDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee (G.K., A.O-T., Y.L.); Department of Pediatrics, Seattle Children's, Seattle, Washington (S.E.S.L.).ORCID 0000-0003-0225-6184
Arzu Onar-ThomasDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee (G.K., A.O-T., Y.L.); Department of Pediatrics, Seattle Children's, Seattle, Washington (S.E.S.L.).ORCID 0000-0003-1005-2413
Yimei LiDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee (G.K., A.O-T., Y.L.); Department of Pediatrics, Seattle Children's, Seattle, Washington (S.E.S.L.).

Funding

COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trialsR50CA275857 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI Sarah Elisabeth Sherr Leary · 2023 to 2026
$701k
NCI NIH HHS R50 CA275857NCI NIH HHS U10 CA180899NIH HHS U10CA180899Statistics & Data Center 5R50CA275857-02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41017640
PMCPMC12916737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.